Yasuhiro Yonetoku

Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists

Ryo Naito, Yasuhiro Yonetoku, Yoshinori Okamoto et al. · Journal of Medicinal Chemistry · 2005 · 151 citations · Full text

Molecular Pharmacology, Bladder Contraction, Antimuscarinic Properties +14

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

S. Yoshida, Hirotsugu Tanaka, Hiroyuki Oshima et al. · Biochemical and Biophysical Research Communications · 2010 · 55 citations

Molecular Pharmacology, Diabetes Management, β-Cell Preservative Agent +11

Peptide Based Interleukin-1.BETA. Converting Enzyme(ICE) Inhibitors: Synthesis, Structure Activity Relationships and Crystallographic Study of the ICE-inhibitor Complex.

Yoshinori Okamoto, Hideki Anan, Eiichi Nakai et al. · Chemical and Pharmaceutical Bulletin · 1999 · 46 citations · Full text

The role of small molecule GPR119 agonist, AS1535907, in glucose‐stimulated insulin secretion and pancreatic <i>β</i> ‐cell function

S. Yoshida, Takahide Ohishi, Taei Matsui et al. · Diabetes Obesity and Metabolism · 2010 · 45 citations

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice

S. Yoshida, Takahide Ohishi, Tetsuo Matsui et al. · Biochemical and Biophysical Research Communications · 2010 · 42 citations

Molecular Pharmacology, Metabolic Syndrome, Insulin Signaling +13